Home / Publication / Understanding the Effect of the HCV Polymerase Inhibitor Mericitabine on Early Viral Kinetics in the Phase 2 JUMP-C and PROPEL Studies

論文

Understanding the Effect of the HCV Polymerase Inhibitor Mericitabine on Early Viral Kinetics in the Phase 2 JUMP-C and PROPEL Studies

Author(s): Ya-Chi Chen, Coen Bernaards, Rohit Kulkarni, Sebastian Moreira, Yonghong Zhu, Anna Chan, Ethan Badman, Andrew Ackrill, James Thommes, Patrick Smith

Year: 2014年8月21日

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

ウェビナー

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

ウェビナー

トランスレーショナル開発における中和ADA効果の薬物動態モデリング

ウェビナー

Extrapolating AUC to Infinity

ブログ

Powered by Translations.com GlobalLink Web Software

Understanding the Effect of the HCV Polymerase Inhibitor Mericitabine on Early Viral Kinetics in the Phase 2 JUMP-C and PROPEL Studies

Understanding the Effect of the HCV Polymerase Inhibitor Mericitabine on Early Viral Kinetics in the Phase 2 JUMP-C and PROPEL Studies

From Data to Decisions: Real-World Impact of Model-Based Meta-Analysis (MBMA) with GSK and Certara

Modernizing NCA Workflows: The Power of ADNCA for Regulatory-Ready Pharmacokinetic Analysis

トランスレーショナル開発における中和ADA効果の薬物動態モデリング

Extrapolating AUC to Infinity

メルマガ登録

クイックアクセス

ソリューション

お問合せ